Call Options Transactions Made in Q3 2024 in Arrowhead Pharmaceuticals, Inc. (ARWR)
This table provides information about the institutional ownership of Arrowhead Pharmaceuticals, Inc. (ARWR) during Q3 2024. The information is specifically focused on institutions that hold call options of ARROWHEAD PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 15, 2024
Q3 2024
|
Barclays PLC
London, X0 |
BUY
|
CALL |
25KNew |
$484K - $739K
|
25K
$491K
|
|
|
Nov 14, 2024
Q3 2024
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
13.7K+ 121.24% |
$265K - $405K
|
25K
$491K
|
|
|
Nov 13, 2024
Q3 2024
|
Gts Securities LLC
New York, NY |
BUY
|
CALL |
10.1KNew |
$196K - $298K
|
10.1K
$198K
|
|
|
Nov 14, 2024
Q3 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
CALL |
-9K- 61.64% |
$174K - $266K
|
5.6K
$110K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-9K- 19.44% |
$174K - $266K
|
37.3K
$732K
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-150K- 75.35% |
$2.9M - $4.43M
|
49K
$962K
|